Filing Flows

Filing Flows › Health Care › Dentsply Sirona (XRAY)

Dentsply Sirona (XRAY) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Nov 5, 2026 · Dentsply Sirona (XRAY) Q3 2026 earnings results →

Q3 2026 Revenue down 8% year over year to $836M · 0¢ of every $1 of revenue lost · operating margin 4.4%

Dentsply Sirona made $836M in Q3 2026 (-8% Y/Y). Operating margin 4.4%, net loss $3.0M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 5, 2026.

Revenue$836M
Year over year-8%
Operating margin4.4%
Net earnings−$3.0M
Operating cash flow$32.0M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $836.0M in Q3 2026, down 8% year over year and down 7% from the previous quarter.

Gross margin was 53.0%, up 4.2 points from Q3 2025. Operating profit was $37.0M, a 4.4% margin (up 28.5 points year over year). Operating expenses fell 38% while revenue fell 8%. The fastest-growing cost line was Research & development (+14%). The quarter ended with a net loss of $3.0M, after a profit of $36.0M the previous quarter. Minority interests bore $1.0M of it: to shareholders the quarter was a loss of $2.0M. Net interest and other expense of $11.0M was the main reason.

Operating cash flow was $32.0M (down 59% year over year). Non-cash charges added back $82.0M of depreciation and amortization and $8.0M of share-based compensation. Working capital and other items used $55.0M. Capital expenditures of $32.0M left free cash flow of $0K.

Quarterly history

Dentsply Sirona revenue by quarterDentsply Sirona revenue by quarter$879MQ1 2025$936MQ2 2025$904MQ3 2025$961MQ4 2025$880MQ1 2026$898MQ2 2026$836MQ3 2026
Dentsply Sirona net earnings by quarterDentsply Sirona net earnings by quarter$20.0MQ1 2025−$44.0MQ2 2025−$428MQ3 2025−$145MQ4 2025−$10.0MQ1 2026$37.0MQ2 2026−$3.0MQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 202610-QNov 5, 2026$836M-8%4.4%−$3.0M$32.0M
Q2 202610-QAug 6, 2026$898M-4%9.1%$37.0M$99.0M
Q1 202610-QMay 5, 2026$880M+0.1%-4.0%−$10.0M$40.0M
Q4 202510-KFeb 26, 2026$961M+6%-14.5%−$145M$101M
Q3 202510-QNov 6, 2025$904M-5%-24.1%−$428M$79.0M
Q2 202510-QAug 7, 2025$936M-5%-13.7%−$44.0M$48.0M
Q1 202510-QMay 8, 2025$879M-8%7.2%$20.0M$7.0M

Charts

Dentsply Sirona: revenue growth, year over year and quarter over quarterDentsply Sirona: revenue growth, year over year and quarter over quarterY/YQ/Q-8%Q1 2025-5%+6%Q2 2025-5%-3%Q3 2025+6%+6%Q4 2025+0%-8%Q1 2026-4%+2%Q2 2026-8%-7%Q3 2026
Latest (Q3 2026): Y/Y -8%, Q/Q -7%.
Dentsply Sirona: where the cash came from (+) and went (−), TTM to Q3 2026Dentsply Sirona: where the cash came from (+) and went (−), TTM to Q3 2026Operating cash flow$272MCapital spending−$169MCash drawn (+) / kept (−)$168MNet borrowing (+) / repaid (−)−$159MDividends−$64.0MBuybacks−$25.0MOther investing−$11.0MOther financing−$9.0MExchange rates−$3.0M
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Dentsply Sirona: profit against cash, quarter by quarterDentsply Sirona: profit against cash, quarter by quarterNet incomeOperating cash flow−$428M$87.0MQ4 2024$19.0M$7.0MQ1 2025−$44.0M$48.0MQ2 2025−$428M$79.0MQ3 2025−$145M$101MQ4 2025−$10.0M$40.0MQ1 2026$36.0M$99.0MQ2 2026−$3.0M$32.0MQ3 2026
Latest (Q3 2026): Net income −$3.0M, Operating cash flow $32.0M.
Dentsply Sirona: diluted shares by fiscal yearDentsply Sirona: diluted shares by fiscal year219MFY2020220MFY2021216MFY2022212MFY2023203MFY2024199MFY2025
-9.0% since FY2020: buybacks shrank the count.
Dentsply Sirona: long-term debt falling due (FY2025)Dentsply Sirona: long-term debt falling due (FY2025)$228M2026$110M2027$177M2028$82.0M2029$832M2030$847MLater
Cash $326M, short-term investments —, long-term debt $2.3B at 2025-12-31.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

Customers and suppliers named in filings

Sells to

About Dentsply Sirona

DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) is the world’s largest diversified manufacturer of professional dental products and technologies, with a 139-year history of innovation and service to the dental industry and a vision of improving oral health and continence care globally. Dentsply Sirona develops, manufactures, and markets comprehensive solutions, including technologically advanced dental equipment supported by cloud-enabled software solutions as well as dental products and healthcare consumable products in urology and enterology under a strong portfolio of world-class brands. Dentsply Sirona’s innovative products provide high-quality, effective, and connected solutions to advance patient care and deliver better, safer, and faster dentistry. Dentsply Sirona’s worldwide headquarters is located in Charlotte, North Carolina.

In its own words, from its 10-K, filed Feb 26, 2026.

Dentsply Sirona against its Dental Equipment & Supplies peers

The largest companies of the same SEC industry, each at its latest quarter.

CompanyQuarterRevenueY/YOp. margin
XRAY Dentsply SironaQ3 2026$836M-8%4.4%
NVST Envista HoldingsQ3 2026$692M+3%74.5%

Source: Dentsply Sirona 10-Q on SEC EDGAR · CIK 818479 · Dental Equipment & Supplies

13F: who owns XRAY and who is buying

Largest holders of XRAY (13F)Largest holders of XRAY (13F)BlackRock$283MVanguard Group$250MFuller & Thaler Asset Management$135MVanguard Portfolio Management LLC$125MAQR Capital Management LLC$110MState Street$98.5MVanguard Capital Management LLC$96.0MLazard Asset Management LLC$87.7MAriel Investments, LLC$85.2MSouthpoint Capital Advisors LP$74.3M
Funds' net buying of XRAY by quarter (13F)Funds' net buying of XRAY by quarter (13F)$49.8M2024-09−$190M2024-12−$24.8M2025-03−$4.0M2025-06$87.6M2025-09$78.5M2025-12−$862K2026-03$137M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on XRAY

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results

Compare XRAY with

中文版:Dentsply Sirona(XRAY)财报

Español · Français